Vertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.

Like many tech stocks, Alphabet's (NASDAQ: GOOGL) (NASDAQ: GOOG) stock pulled back in recent months. Investors still question ...

Mathematicians struggled to find the fewest number of pieces needed to cut an equilateral triangle and rearrange it into a ...

Now, more than 122 years after it was first proposed, Kamata and two other mathematicians have finally proved that a solution ...

Vertex Pharmaceuticals is flexing its innovation muscles beyond its cystic fibrosis stronghold, charging into new territories ...

There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

Learn more about whether Elastic N.V. or Vertex, Inc. is a better investment based on AAII's A+ Investor grades, which ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

This crypto market today piece looks at why popular DEX tokens like CAKE, HYPE, and UNI prices are doing well after the FOMC ...

By Brenden Bobby Reader Columnist In case you forgot, Pi Day is Friday, March 14 — a celebration of one of the most important numbers in our universe: 3.14159.  Pi is the ratio ...

Text-based interfaces for creating text, graphics, and other content have received the majority of attention in the field of generative ...